CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
856-870 of 1196
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
MinuteCE®Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
MinuteCE®Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
Nicoletta Colombo, MD
Susana Campos, MD, MPH
Emerging immunotherapy combination strategies in genitourinary malignancies
MinuteCE®Emerging immunotherapy combination strategies in genitourinary malignancies
Sandy Srinivas, MD
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CEAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
- advertisement
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
MinuteCE®Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
Pasi Antero Jänne, MD, PhD
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
MinuteCE®Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
MinuteCE®Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
MinuteCE®Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
- advertisement
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
MinuteCE®CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
CME/CEThe Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
